These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 19509486)
1. Has pharmacogenetics brought us closer to 'personalized medicine' for initial drug treatment of hypertension? Arnett DK; Claas SA; Lynch AI Curr Opin Cardiol; 2009 Jul; 24(4):333-9. PubMed ID: 19509486 [TBL] [Abstract][Full Text] [Related]
5. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154 [TBL] [Abstract][Full Text] [Related]
6. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768 [TBL] [Abstract][Full Text] [Related]
7. Hypertension pharmacogenomics: in search of personalized treatment approaches. Cooper-DeHoff RM; Johnson JA Nat Rev Nephrol; 2016 Feb; 12(2):110-22. PubMed ID: 26592190 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of antihypertensive drug response. Kreutz R Curr Hypertens Rep; 2004 Feb; 6(1):15-20. PubMed ID: 14972084 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics considerations in the control of hypertension. Lupoli S; Salvi E; Barcella M; Barlassina C Pharmacogenomics; 2015 Nov; 16(17):1951-64. PubMed ID: 26555875 [TBL] [Abstract][Full Text] [Related]
10. The antihypertensive response to irbesartan treatment from a pharmacogenetic perspective. Kurland L Minerva Med; 2003 Aug; 94(4):251-8. PubMed ID: 14605589 [TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of antihypertensive drug responses. Schwartz GL; Turner ST Am J Pharmacogenomics; 2004; 4(3):151-60. PubMed ID: 15174896 [TBL] [Abstract][Full Text] [Related]
13. An update on the pharmacogenetics of treating hypertension. Fontana V; Luizon MR; Sandrim VC J Hum Hypertens; 2015 May; 29(5):283-91. PubMed ID: 25355012 [TBL] [Abstract][Full Text] [Related]
14. Antihypertensive pharmacogenetics: getting the right drug into the right patient. Turner ST; Schwartz GL; Chapman AB; Hall WD; Boerwinkle E J Hypertens; 2001 Jan; 19(1):1-11. PubMed ID: 11204288 [TBL] [Abstract][Full Text] [Related]
15. The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study. Do AN; Lynch AI; Claas SA; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Tiwari HK; Arnett DK; Irvin MR J Hum Hypertens; 2016 Sep; 30(9):549-54. PubMed ID: 26791477 [TBL] [Abstract][Full Text] [Related]
20. Do genetic variants of the Renin-Angiotensin system predict blood pressure response to Renin-Angiotensin system-blocking drugs?: a systematic review of pharmacogenomics in the Renin-Angiotensin system. Konoshita T; Curr Hypertens Rep; 2011 Oct; 13(5):356-61. PubMed ID: 21562941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]